lys1 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Thermo Fisher anti cd5
    Analysis of <t>CD5</t> − B220 − cells in the spleens of chronically infected mice subjected to different parasite loads at the acute phase of T. cruzi infection. Mice were infected with 10 3 (low dose) or 10 5 (high dose) parasites and treated at day 6 with benznidazole. One year after infection, spleen cell suspensions were analyzed by fluorescence-activated cell sorting. (A) Frequency of CD5 − B220 − cells; (B) total numbers of CD5 − B220 − cells per spleen; (C) frequency of Ia + B220 − cells; (D) correlation between frequencies of CD5 − B220 − cells and total numbers of spleen cells. Each bar represents the mean ± standard error of individual values from 10 or 11 mice. ∗, P
    Anti Cd5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd5/product/Thermo Fisher
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti cd5 - by Bioz Stars, 2022-12
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec cd5 ly 1 microbeads
    Analysis of <t>CD5</t> − B220 − cells in the spleens of chronically infected mice subjected to different parasite loads at the acute phase of T. cruzi infection. Mice were infected with 10 3 (low dose) or 10 5 (high dose) parasites and treated at day 6 with benznidazole. One year after infection, spleen cell suspensions were analyzed by fluorescence-activated cell sorting. (A) Frequency of CD5 − B220 − cells; (B) total numbers of CD5 − B220 − cells per spleen; (C) frequency of Ia + B220 − cells; (D) correlation between frequencies of CD5 − B220 − cells and total numbers of spleen cells. Each bar represents the mean ± standard error of individual values from 10 or 11 mice. ∗, P
    Cd5 Ly 1 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd5 ly 1 microbeads/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cd5 ly 1 microbeads - by Bioz Stars, 2022-12
    94/100 stars
      Buy from Supplier

    95
    Thermo Fisher anti human cd20
    Distribution of TILs in pNENs and PDACs. The number of TILs in PDACs, NETs, and NECs was counted using the expression of CD3, CD3+/CD4, CD3+/CD8, <t>CD20,</t> CD204, CD3+/PD-1, and CD204+/PD-L1. P-values less than 0.05 were considered statistically significant. N.S., not significant.
    Anti Human Cd20, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd20/product/Thermo Fisher
    Average 95 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti human cd20 - by Bioz Stars, 2022-12
    95/100 stars
      Buy from Supplier

    Image Search Results


    Analysis of CD5 − B220 − cells in the spleens of chronically infected mice subjected to different parasite loads at the acute phase of T. cruzi infection. Mice were infected with 10 3 (low dose) or 10 5 (high dose) parasites and treated at day 6 with benznidazole. One year after infection, spleen cell suspensions were analyzed by fluorescence-activated cell sorting. (A) Frequency of CD5 − B220 − cells; (B) total numbers of CD5 − B220 − cells per spleen; (C) frequency of Ia + B220 − cells; (D) correlation between frequencies of CD5 − B220 − cells and total numbers of spleen cells. Each bar represents the mean ± standard error of individual values from 10 or 11 mice. ∗, P

    Journal: Infection and Immunity

    Article Title: Influence of Acute-Phase Parasite Load on Pathology, Parasitism, and Activation of the Immune System at the Late Chronic Phase of Chagas' Disease

    doi:

    Figure Lengend Snippet: Analysis of CD5 − B220 − cells in the spleens of chronically infected mice subjected to different parasite loads at the acute phase of T. cruzi infection. Mice were infected with 10 3 (low dose) or 10 5 (high dose) parasites and treated at day 6 with benznidazole. One year after infection, spleen cell suspensions were analyzed by fluorescence-activated cell sorting. (A) Frequency of CD5 − B220 − cells; (B) total numbers of CD5 − B220 − cells per spleen; (C) frequency of Ia + B220 − cells; (D) correlation between frequencies of CD5 − B220 − cells and total numbers of spleen cells. Each bar represents the mean ± standard error of individual values from 10 or 11 mice. ∗, P

    Article Snippet: Spleen cells were double stained in suspension with anti-CD5 and anti-B220, anti-Ia and anti-CD8, or anti-CD4 (all from Gibco BRL, Gaithersburg, Md.) and anti-CD45RB monoclonal antibodies (MAbs) (clones 16A and 23G2) (PharMingen, San Diego, Calif.), labeled with phycoerythrin or fluorescein isothiocyanate.

    Techniques: Infection, Mouse Assay, Fluorescence, FACS, IA

    Distribution of TILs in pNENs and PDACs. The number of TILs in PDACs, NETs, and NECs was counted using the expression of CD3, CD3+/CD4, CD3+/CD8, CD20, CD204, CD3+/PD-1, and CD204+/PD-L1. P-values less than 0.05 were considered statistically significant. N.S., not significant.

    Journal: Scientific Reports

    Article Title: Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification

    doi: 10.1038/s41598-018-31383-9

    Figure Lengend Snippet: Distribution of TILs in pNENs and PDACs. The number of TILs in PDACs, NETs, and NECs was counted using the expression of CD3, CD3+/CD4, CD3+/CD8, CD20, CD204, CD3+/PD-1, and CD204+/PD-L1. P-values less than 0.05 were considered statistically significant. N.S., not significant.

    Article Snippet: The primary antibodies used were as follows: anti-human cluster of differentiation (CD)3 (clone SP7, Abcam, Cambridge, UK; ab16669, 1:200 dilution), anti-human CD4 (clone 4B12, Novocastra, Newcastle, UK; NCL-L-CD4-368, 1:200 dilution), anti-human CD8 (clone 4B11, Novocastra; NCL-L-CD8-4B11, 1:160 dilution), anti-human CD20 (clone L26, Thermo Fisher Scientific, Rockfold, IL, USA; MA5-13141, 1:100 dilution), anti-human CD204 (SRA-E5, TransGenic Inc., Fukuoka, Japan; KT022, 1:200 dilution), anti-human PD-1 (EH33, Cell Signaling Technology, Danvers, USA; #43248S, 1:200 dilution), anti-human PD-L1 (clone E1L3N, Cell Signaling Technology; #13684P, 1:1200 dilution), and cytokeratin (clone AE1/AE3, Dako; IR053, 1:100 dilution).

    Techniques: Expressing

    Distribution of TILs in the 50 NETs analysed in this study according to tumour grade (G1/G2/G3). The number of TILs in the 50 NETs identified in this study was counted using the expression of CD3, CD3+/CD4, CD3+/CD8, CD20, CD204, CD3+/PD-1, and CD204+/PD-L1.

    Journal: Scientific Reports

    Article Title: Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification

    doi: 10.1038/s41598-018-31383-9

    Figure Lengend Snippet: Distribution of TILs in the 50 NETs analysed in this study according to tumour grade (G1/G2/G3). The number of TILs in the 50 NETs identified in this study was counted using the expression of CD3, CD3+/CD4, CD3+/CD8, CD20, CD204, CD3+/PD-1, and CD204+/PD-L1.

    Article Snippet: The primary antibodies used were as follows: anti-human cluster of differentiation (CD)3 (clone SP7, Abcam, Cambridge, UK; ab16669, 1:200 dilution), anti-human CD4 (clone 4B12, Novocastra, Newcastle, UK; NCL-L-CD4-368, 1:200 dilution), anti-human CD8 (clone 4B11, Novocastra; NCL-L-CD8-4B11, 1:160 dilution), anti-human CD20 (clone L26, Thermo Fisher Scientific, Rockfold, IL, USA; MA5-13141, 1:100 dilution), anti-human CD204 (SRA-E5, TransGenic Inc., Fukuoka, Japan; KT022, 1:200 dilution), anti-human PD-1 (EH33, Cell Signaling Technology, Danvers, USA; #43248S, 1:200 dilution), anti-human PD-L1 (clone E1L3N, Cell Signaling Technology; #13684P, 1:1200 dilution), and cytokeratin (clone AE1/AE3, Dako; IR053, 1:100 dilution).

    Techniques: Expressing

    Principal component analysis of 52 pNEN and 18 PDAC patients. PCA plots of 7 variables, which includes CD3, CD4, CD8, CD20, CD204, PD-1, and PD-L1 in the epithelial area, are shown for all 70 samples. There is a clear separation of three clusters according to the histologic type of NETs, including G1/G2/G3, NECs, and PDACs.

    Journal: Scientific Reports

    Article Title: Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification

    doi: 10.1038/s41598-018-31383-9

    Figure Lengend Snippet: Principal component analysis of 52 pNEN and 18 PDAC patients. PCA plots of 7 variables, which includes CD3, CD4, CD8, CD20, CD204, PD-1, and PD-L1 in the epithelial area, are shown for all 70 samples. There is a clear separation of three clusters according to the histologic type of NETs, including G1/G2/G3, NECs, and PDACs.

    Article Snippet: The primary antibodies used were as follows: anti-human cluster of differentiation (CD)3 (clone SP7, Abcam, Cambridge, UK; ab16669, 1:200 dilution), anti-human CD4 (clone 4B12, Novocastra, Newcastle, UK; NCL-L-CD4-368, 1:200 dilution), anti-human CD8 (clone 4B11, Novocastra; NCL-L-CD8-4B11, 1:160 dilution), anti-human CD20 (clone L26, Thermo Fisher Scientific, Rockfold, IL, USA; MA5-13141, 1:100 dilution), anti-human CD204 (SRA-E5, TransGenic Inc., Fukuoka, Japan; KT022, 1:200 dilution), anti-human PD-1 (EH33, Cell Signaling Technology, Danvers, USA; #43248S, 1:200 dilution), anti-human PD-L1 (clone E1L3N, Cell Signaling Technology; #13684P, 1:1200 dilution), and cytokeratin (clone AE1/AE3, Dako; IR053, 1:100 dilution).

    Techniques: